Krebs Biochemicals & Industries Limited (KREBSBIO.NS)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Jitendra Rameshchandra Shah | MD, CEO & Director | 20k | -- | 1968 |
Mr. Ritesh Jain | Chief Financial Officer | -- | -- | -- |
Mr. Rakesh R. Kalbate | Company Secretary & Compliance Officer | -- | -- | -- |
Krebs Biochemicals & Industries Limited
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 191
Description
Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. The company was incorporated in 1991 and is based in Visakhapatnam, India.
Corporate Governance
Upcoming Events
May 19, 2025 at 10:59 AM UTC - May 23, 2025 at 12:00 PM UTC
Krebs Biochemicals & Industries Limited Earnings Date
Recent Events
September 14, 2005 at 12:00 AM UTC
Ex-Dividend Date